Russell Clayton
Chief Tech/Sci/R&D Officer at LARIMAR THERAPEUTICS, INC.
Net worth: 142 425 $ as of 2024-04-29
Profile
Russell G.
Clayton is currently the Chief Medical Officer at Larimar Therapeutics, Inc. He previously worked as the Regional Medical Director-Scientific Affairs at Merck & Co., Inc., Director-Asthma Program Division at The Children's Hospital of Philadelphia Foundation, Vice President-Research & Development at Windtree Therapeutics, Inc., and Chief Medical Officer at Alcresta Therapeutics, Inc. He received his undergraduate degree from LaSalle University and his doctorate from Philadelphia College of Osteopathic Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-16 | 22,500 ( 0.04% ) | 142 425 $ | 2024-04-29 |
Russell Clayton active positions
| Companies | Position | Start |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-07-16 |
Former positions of Russell Clayton
| Companies | Position | End |
|---|---|---|
Alcresta Therapeutics, Inc.
 Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Chief Tech/Sci/R&D Officer | 2017-03-31 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | - |
The Children's Hospital of Philadelphia Foundation
 The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| WINDTREE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Russell Clayton
| LaSalle University | Undergraduate Degree |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| WINDTREE THERAPEUTICS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| LARIMAR THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
The Children's Hospital of Philadelphia Foundation
The Children's Hospital of Philadelphia Foundation Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia Foundation operates charitable organizations for children's health care. It conducts programs on patient care, research, and clinical education. The company was founded in 1855 and is headquartered in Philadelphia, PA. | Health Services |
Alcresta Therapeutics, Inc.
Alcresta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Alcresta Therapeutics, Inc. engages in the development of enzyme-based products designed to address challenges faced by people living with gastrointestinal disorders and rare diseases. It offers products designed to improve the delivery, digestion, and absorption of long-chain polyunsaturated fatty acids or LCPUFAs. The company was founded by Robert Gallotto and Dr. Alexey L. Margolin in 2011 and is headquartered in Newton, MA. | Health Technology |
- Stock Market
- Insiders
- Russell Clayton
